Todd Whitson
Karius has appointed Todd Whitson as chief commercial officer. Whitson joins Karius from CareDx where he served as CCO. Prior to CareDx, he served as VP of commercial operations for Ariosa Diagnostics, now part of Roche, and led sales at Genzyme Genetics, later acquired by LabCorp.
Ena Cratsenburg, Will Schroeder
Ginkgo Bioworks has appointed Ena Cratsenburg as chief business officer and Will Schroeder as head of metabolic engineering. Cratsenburg joins Ginkgo with over a decade of experience in business development in the biotech space. She has held positions as senior VP of the consumer sector at Intrexon, senior VP of business development at Evolva, and VP of business development for Amyris. Schroeder joins Ginkgo from Archer Daniels Midland (ADM) where he served as CP of technology. Before ADM, Schroeder spent 12 years at Cargill, overseeing strain and fermentations process development.
Chris van Ingen
Chris van Ingen, a former member of Bruker's board of directors, died on June 27, Bruker said in a document filed with the US Securities and Exchange Commission. van Ingen died less than a week after he told the firm that he would be retiring from the board due to medical reasons. The cause of his death was not disclosed. He had been on Bruker's board since 2012. From 2001 to 2007, van Ingen was with Agilent Technologies where he served as president of the firm's bio-analytical measurement business.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.